CacheBy
Thermo Fisher Scientific Human RGS22 Synthetic Peptide
원본

Thermo Fisher Scientific Human RGS22 Synthetic Peptide

상품 한눈에 보기

Human RGS22 단백질의 N-말단 19개 아미노산 서열에 해당하는 합성 펩타이드. PA5-34426 항체의 블로킹 펩타이드로 사용 가능. PBS(pH 7.2), 0.1% BSA, 0.02% sodium azide 함유. -20°C 보관. 연구용으로만 사용.

카탈로그번호
PEP1468
카테고리
Protein
판매단위
pk
카탈로그 보기

카탈로그

1개 옵션
회원가입 없이 바로 구매하세요
가입하지 않아도 비회원가로 구매하실 수 있습니다.
마지막 업데이트 2025. 07. 31. 오전 07:49
Thermo Fisher Scientific PEP1468 Human RGS22 Synthetic Peptide 50 ug pk판매 단위 pk ·
재고 확인 필요
195,500원VAT 포함 215,050원

Thermo Fisher Scientific · Thermo Fisher Scientific Human RGS22 Synthetic Peptide

Applications

Control (Ctrl)

  • Assay-dependent

Blocking Assay (BLOCK)

  • Assay-dependent

Product Specifications

항목 내용
Species Reactivity Human
Class Synthetic
Type Peptide
Conjugate Unconjugated
Form Liquid
Concentration 200 µg/mL
Purification Purified
Storage Buffer PBS, pH 7.2, with 0.1% BSA
Contains 0.02% sodium azide
Storage Conditions -20°C

Product Specific Information

This peptide corresponds to a 19 amino acid sequence near the amino terminus of human RGS22.
PEP-1468 can be used as a blocking peptide with polyclonal antibody PA5-34426.

Target Information

Regulator of G-protein signaling (RGS) proteins contain a conserved 120 amino acid RGS domain that functions as a GTPase-activating protein to reduce signaling from receptor-activated G-alpha subunits.
RGS22 is a recently identified member of this family, localized to the testis, and interacts with guanine nucleotide-binding proteins alpha 11, 12, and 13 (GNA11, GNA12, GNA13).
Although RGS22 is implicated in spermiogenesis, it is also expressed in several epithelial-origin cancer cell lines and associated with cancer metastasis. Overexpression of RGS22 in highly metastatic cancer cells decreases migration and invasiveness, suggesting its potential as a prognostic biomarker for metastasis.


For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.

Thermo Fisher Scientific 상품 둘러보기

전체보기

문의

0

아직 등록된 문의가 없어요.